Diversity amongst Early Career Scientist attendees and their participation at the annual EGU General Assembly: from in-person to online meetings

2021 ◽  
Author(s):  
Anouk Beniest ◽  
Claudia Alves de Jesus-Rydin ◽  
Lisa Wingate ◽  
Elenora van Rijsingen ◽  
Andrea Popp ◽  
...  
Keyword(s):  
Science Research ◽  
Time Frame ◽  
Absolute Number ◽  
Early Career ◽  
General Assembly ◽  
Career Stage ◽  
Age Group ◽  
The Past ◽  
Emerging Trends ◽  
Online Format

<p>The European Geosciences Union (EGU) is the leading organisation for Earth, planetary and space science research in Europe. Each year the EGU holds its General Assembly (GA), which is the largest and most prominent geosciences event in Europe, attracting over 16,000 scientists from all over the world in the year 2019. In 2020 the General Assembly transitioned to a completely virtual format in response to the global COVID-19 pandemic, with approximately 20,000 members participating. Using self-declared data provided by participants during the registration phase of the annual general assembly we were interested to learn how the attendance of Early Career Scientists (ECS) at the general assembly had evolved over recent years and especially during the transition to the fully online format. Within the EGU an ‘Early Career Scientist’ is defined as ‘a student, a PhD candidate or a practicing scientist who received their highest degree (e.g. BSc, MSc or PhD) within the past seven years’, with some exceptions to this time-frame that account for research career breaks. As ECS account for about half of the total EGU membership we tested whether there were any emerging trends in the database regarding the number of ECS attending the meeting between 2015 and 2020 and whether there were any shifts in the diversity of ECS with respect to gender and age during the same timeframe.</p><p>We observed a general increase (5-30%) in ECS participation from 2015 until 2020 irrespective of gender. In 2019, the total increase of all participants stalled, but the overall number of ECS participants still increased with 12%.</p><p>Around 55% of the ECS fall within the age-group ‘26-35 years' and a further 10% in the '18-25 years' group. These percentages have been very constant through the years, apart from the age-group ’36-45 years, which has seen a slight increase from 10-14% over the past years. All groups have seen an increase in the absolute number of ECS participants during the physical meetings. However, a continuation of this trend is less clear during the online GA, as about 60% of the ECS members refrained from sharing their age.</p><p>We also investigated to what extent ECS participate as conveners in scientific sessions. About 10-12% of the ECS members are active as conveners during the GA, with the majority self-declaring as male. Only during the virtual GA in 2020 did the number of women conveners equal the numbers for men. We observed an increase in the representation of ECS of the total convener’s pool from 30% to 43% during the physical GA’s. During the online GA in 2020 ECS representation was 31%.</p><p>One consideration with the ECS status of members, is that depending on someones career stage, privacy reasons, and the awareness of our members about the ECS definition, not all members who would qualify for the ECS status, are in our system as such, because it is a self-declared status. This data is extremely important as it allows the EGU to track the success and developments of initiatives that support ECS career and conference experiences.</p>

Gender and career-stage distribution at EGU General Assemblies

2020 ◽  
Author(s):  
Elena Toth ◽  
Claudia Jesus-Rydin ◽  
Alberto Montanari
Keyword(s):  
Gender Gap ◽  
Science Research ◽  
Early Career ◽  
General Assembly ◽  
Career Stage ◽  
Stage Distribution ◽  
Academic History ◽  
Gender Information ◽  
Noticeable Improvement ◽  
History Of

<p>The European Geosciences Union (EGU) is the leading organisation for Earth, planetary and space science research in Europe. The annual EGU General Assembly is the largest and most prominent European geosciences event, attracting over 16,000 scientists from all over the world in the year 2019. <br>This presentation aims to present the results from gender and career stage distribution at the last (2015 to 2019) EGU General Assemblies (GA).  Data and statistics will be presented not only on the attendance, but also to the role in the general assembly, i.e. author, convener, presenter.<br>As expected, given the academic history of the geosciences as a male - dominated field, a gender gap is observed, with an overall gender breakdown of EGU GA’s attendance of about one third of women and two thirds of men; on the other hand, the fraction of female attendees is very slightly but constantly increasing in the years (and not only among early-career scientists). The percentage of female attendees in fact passed from 32.6% in 2015 to 33.8% in 2018 (the percentage in 2019 was even greater, but in that year the number of those who provided gender information dropped from 17% to 30%, so we consider the last year the less informative for the gender analysis).<br>In addition, when looking at organisational roles, much steeper is the increase in the fraction of female conveners: in fact the percentage of female conveners was 30.1% in 2018, that is much closer to that of the overall female attendees, whereas it was about 25.9% only 3 years earlier.<br>Looking at career stages, the percentage of early-career scientists among the overall attendees is substantially increased in the last years (from 43% in 2015 to 52% in 2019), and also in this case, the fraction of early-career conveners steeply raised too (from 30% in 2015 to 43% in 2019).<br>The analysis on the number of conveners, even if there is still a skew towards male and mid-career or senior scientists, shows that there has been a noticeable improvement in the balance of gender and career-stage over the last years in terms of key-roles in the organisation of the main EGU event.<br>Despite such improvement in term of convenorship, more can certainly be done inside the Union, and an attempt to provide constructive indications to further steps to the target of giving equal opportunities to researchers across gender and career-stage will also be given.</p>

scholarly journals Use of all cause mortality to quantify the consequences of covid-19 in Nembro, Lombardy: descriptive study

BMJ ◽  
2020 ◽  
pp. m1835 ◽  
Author(s):  
Marco Piccininni ◽  
Jessica L Rohmann ◽  
Luca Foresti ◽  
Caterina Lurani ◽  
Tobias Kurth
Keyword(s):  
Descriptive Study ◽  
Time Frame ◽  
Absolute Number ◽  
Northern Italy ◽  
Age Group ◽  
Small Community ◽  
All Cause Mortality ◽  
Considerable Impact ◽  
Italian City ◽  
The Impact

Abstract Objective To quantify the impact of coronavirus disease 2019 (covid-19) on all cause mortality in Nembro, an Italian city severely affected by the covid-19 pandemic. Design Descriptive study. Setting Nembro, in the Bergamo province of Lombardy, northern Italy. Population Residents of Nembro. Main outcome measures Monthly all cause mortality between January 2012 and April 2020 (data to 11 April), number of confirmed deaths from covid-19 to 11 April 2020, and weekly absolute number of deaths between 1 January and 4 April across recent years by age group and sex. Results Nembro had 11 505 residents as of 1 January 2020. Monthly all cause mortality between January 2012 and February 2020 fluctuated around 10 per 1000 person years, with a maximum of 21.5 per 1000 person years. In March 2020, monthly all cause mortality reached a peak of 154.4 per 1000 person years. For the first 11 days in April, this rate decreased to 23.0 per 1000 person years. The observed increase in mortality was driven by the number of deaths among older people (≥65 years), especially men. From the outbreak onset until 11 April 2020, only 85 confirmed deaths from covid-19 in Nembro were recorded, corresponding to about half of the 166 deaths from all causes observed in that period. Conclusions The study findings show how covid-19 can have a considerable impact on the health of a small community. Furthermore, the results suggest that the full implications of the covid-19 pandemic can only be completely understood if, in addition to confirmed deaths related to covid-19, consideration is also given to all cause mortality in a given region and time frame.

An Audacious Argument for Modesty

PMLA ◽  
2020 ◽  
Vol 135 (5) ◽  
pp. 970-975
Author(s):  
Michael Bérubé
Keyword(s):  
Graduate Programs ◽  
Early Career ◽  
Career Stage ◽  
Job Market ◽  
The Past ◽  
Epistemic Modesty ◽  
Critical Production

It is notable that Pardis Dabashi's paper at the 2019 MLA convention, “the pressure to intervene: A case for the modest (Young) Critic,” caused such a stir—insofar as it mounted a gentle argument against ritual stir-causing, and the gentleness of the argument was central to its point. As Dabashi wrote, “the language of the scholarly intervention—that is, the articulation of the stakes of one's argument—has a way of ossifying hunches into convictions” (4). The idea, clearly, was to ratchet down the level of agon and hubris in scholarly debate and to foreground the perspectives of younger scholars making their first forays into the fray: “since thus far the post-critical debates held in widely circulated and visible academic forums have mostly been conducted among professionally secure, mid-late career scholars, we've not yet had the chance to discuss the kind of epistemic modesty that matters very deeply to early-career-stage scholars now, that is, scholars entering graduate programs in or around 2008” (2). Dabashi suspects, at least as this professionally secure, mid-to-late-career scholar hears her, that the cohort entering the desiccated post-2008 (and especially post-2015) job market does not see the profession in the terms that have dominated debate about the purpose of criticism over the past ten or twelve years: The field of critical production for us is deeply heterogenous, syncretic: the mixing of critical and (at least some) postcritical methods has become something we take for granted. And early-career scholars of this generation—who don't really have a horse in the race of re-orientating ourselves vis-à-vis the text—would advocate instead, it seems to me, for re-orienting ourselves vis-à-vis each other—that is, laterally, scholar to scholar. (3)

Bioethics In Neurospinal Patient Care

2018 ◽  
Vol 1 (2) ◽  
pp. 1
Author(s):  
Andi Asadul Islam
Keyword(s):  
Time Frame ◽  
Hippocratic Oath ◽  
Moral Vision ◽  
Human Identity ◽  
The Past ◽  
Harvey Cushing ◽  
Sharp Focus ◽  
Realistic Approach ◽  
Cord Injury

Neurosurgery is among the newest of surgical disciplines, appearing in its modern incarnation at the dawn of twentieth century with the work of Harvey Cushing and contemporaries. Neurosurgical ethics involves challenges of manipulating anatomical locus of human identity and concerns of surgeons and patients who find themselves bound together in that venture.In recent years, neurosurgery ethics has taken on greater relevance as changes in society and technology have brought novel questions into sharp focus. Change of expanded armamentarium of techniques for interfacing with the human brain and spine— demand that we use philosophical reasoning to assess merits of technical innovations.Bioethics can be defined as systematic study of moral challenges in medicine, including moral vision, decisions, conduct, and policies related to medicine. Every surgeon should still take the Hippocratic Oath seriously and consider it a basic guide to follow good medical ethics in medical practice. It is simple and embodies three of the four modern bioethics principles – Respecting autonomy, beneficence, nonmaleficence, and justice.Spinal cord injury (SCI) is a devastating condition often affecting young and healthy individuals around the world. Currently, scientists are pressured on many fronts to develop an all-encompassing “cure” for paralysis. While scientific understanding of central nervous system (CNS) regeneration has advanced greatly in the past years, there are still many unknowns with regard to inducing successful regeneration. A more realistic approach is required if we are interested in improving the quality of life of a large proportion of the paralyzed population in a more expedient time frame.

Upcoming Drifts In Bio-Similars

2020 ◽  
Vol 15 ◽  
Author(s):  
Geeta Aggarwal ◽  
Manju Nagpal ◽  
Ameya Sharma ◽  
Vivek Puri ◽  
Gitika Arora Dhingra
Keyword(s):  
Metabolic Diseases ◽  
Market Competition ◽  
Current Status ◽  
Medicinal Products ◽  
The Past ◽  
Biologic Activity ◽  
Emerging Trends ◽  
Regulatory Guidelines ◽  
Food Drug Administration ◽  
Insight Into

Background: Biopharmaceuticals such as Biologic medicinal products have been in clinical use over the past three decades and have benefited towards the therapy of degenerative and critical metabolic diseases. It is forecasted that market of biologics will be going to increase at a rate of 20% per year, and by 2025, more than ˃ 50% of new drug approvals may be biological products. The increasing utilization of the biologics necessitates for cost control, especially for innovators products that have enjoyed a lengthy period of exclusive use. As the first wave of biopharmaceuticals is expired or set to expire, it has led to various opportunities for the expansion of bio-similars i.e. copied versions of original biologics with same biologic activity. Development of biosimilars is expected to promote market competition, meet worldwide demand, sustain the healthcare systems and maintain the incentives for innovation. Methods: Appraisal of published articles from peer reviewed journals, PubMed literature, latest news and guidelines from European Medicine Agency, US Food Drug Administration (FDA) and India are used to identify data for review. Results: Main insight into the quality requirements concerning biologics, current status of regulation of biosimilars and upcoming challenges lying ahead for the upgrading of marketing authorization of bio-similars has been incorporated. Compiled literature on therapeutic status, regulatory guidelines and the emerging trends and opportunities of biosimilars has been thoroughly stated. Conclusion: Updates on biosimilars will support to investigate the possible impact of bio-similars on healthcare market.

Sign in / Sign up

Export Citation Format

Share Document